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Background: An emerging Hi-C protocol has the ability to probe three-dimensional (3D) architecture and capture
chromatin interactions in a genome-wide scale. It provides informative results to address how chromatin
organization changes contribute to disease/tumor occurrence and progression in response to stimulation of
environmental chemicals or hormones.
Results: In this study, using MCF7 cells as a model system, we found estrogen stimulation significantly impact
chromatin interactions, leading to alteration of gene regulation and the associated histone modification states.
Many chromosomal interaction regions at different levels of interaction frequency were identified. In particular, the
top 10 hot regions with the highest interaction frequency are enriched with breast cancer specific genes.
Furthermore, four types of E2-mediated strong differential (gain- or loss-) chromosomal (intra- or inter-) interactions
were classified, in which the number of gain-chromosomal interactions is less than the number of
loss-chromosomal interactions upon E2 stimulation. Finally, by integrating with eight histone modification marks,
DNA methylation, regulatory elements regions, ERα and Pol-II binding activities, associations between epigenetic
patterns and high chromosomal interaction frequency were revealed in E2-mediated gene regulation.
Conclusions: The work provides insight into the effect of chromatin interaction on E2/ERα regulated downstream
genes in breast cancer cells.Background
An intriguing question in biology is how are genes orga-
nized and regulated in the three dimensional space of the
nucleus. Transcriptional regulation was thought to be one
dimensional along the linear genomic DNA sequence until
the wide application of chromatin structure capture experi-
ments, such as Fluorescence In Situ Hybridization (FISH)
[1] and Chromatin Conformation Capture (3C) assay [2].
A recent Hi-C protocol, an emerging high throughput
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reproduction in any medium, provided the or(3D) architecture and capture chromatin interactions in
a genome-wide scale [3]. In the study, Lieberman-Aiden
et al. modeled the Hi-C data as a probability matrix at a
large scale (1 Mb resolution) and revealed the folding
principles of genome organization with a sub-domain of
chromatin to form genome-wide compartments. How-
ever, this study did not quantitatively correlate the 3D
chromatin interactions with epigenetic marks, gene
expression profiling, and transcriptional regulation.
Among the recent efforts to study the effect of genomic
chromatin organization on gene regulation, one study
[4] showed high correlation between binding sites of
CCCTC-binding factor (CTCF) and chromatin inter-
action identified using the Hi-C data [3]. However,
it still lacked in the utilization of other publicly availa-
ble resources such as epigenetic modifications data.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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can only depict a static chromatin structure. Thus, the
questions of how the chromatin organization changes
upon environmental stimulation such as hormone and
chemicals and how these genomic interactions are asso-
ciated with disease development and progression re-
mains elusive.
In this study, utilizing an estrogen receptor-α (ERα)
positive breast cancer cell line, MCF7, before (control)
and after estrogen treatment (E2-treated) as a model
system, we investigate these biological questions and ad-
dress how E2 stimulation will affect chromatin interac-
tions resulting in altering gene regulation and their
relations with epigenetic modification states. About
~75% breast tumors is in response of estrogen through
ERα, which has been reported to regulate distant tar-
get genes by long-range chromatin interactions in our
previous study [5]. Other previous studies have also
linked chromatin organization changes to ERα positive
patients and prognoses of the disease [5-11]. Thus, it
is reasonable to speculate that these chromatin struc-
ture changes contribute to tumor development and
proliferation.
To further address this at a genome-wide scale, we
performed the Hi-C protocol in MCF7 cells at E2-
treated and control conditions. We identified chromo-
somal interacting regions with different levels of inter-
acting frequency as well as E2-mediated differential
chromosomal interactions, and further correlated them
with eight histone modification marks, DNA methyla-
tion, regulatory elements regions, ERα and Pol-II bind-
ing activities. By integrating different ‘omics data in
MCF7 cells, we sought to reveal associations between
high frequent interaction regions, differential chromo-
somal interactions, epigenetic modifications and gene
regulations upon E2 stimulation, and to provide insight
into the effect of chromatin interaction on E2/ERα regu-
lated downstream genes in breast cancer cells.Table 1 Distribution of chromosomal interaction frequency in
of regions with interaction frequency greater than and equal
shown respectively









Identification of E2-mediated high frequency
chromosomal interacting regions
We applied the Hi-C method [3], an experimental proto-
col developed for identifying genome-wide high order
chromosomal interacting regions, to the E2-treated and
control conditions in MCF7 cells. MCF7 is a model breast
cancer cell line widely used for mechanistic studying of
ERα positive breast cancer. A total of ~111 and ~125 mil-
lions of raw paired sequence reads were obtained for E2-
treated and control conditions respectively. Of them, ~80
and ~92 millions reads were uniquely mapped to the
human genome. We then divided the whole genome into
a 1 Mb window-size of chromosome regions, followed by
calculating a Z-score (see the Methods) for each chromo-
some region [12], where a Z-score measures how many
standard deviations an observed value is above or below
the mean value. This was used to illustrate the relative in-
tensity of chromosomal interactions in a 1Mb resolution.
For example, a higher positive Z-score indicates the
observed chromosome region has a much higher inter-
action frequency than the average. We then constructed
genome-wide chromosomal interaction matrices for both
E2-treated and control conditions as shown in Additional
file 1: Figures S1a,b respectively. We further computed
chromosomal interaction frequency for every 1Mb region
based on the Z-score, i.e. the number of non-zero Z-
scores in the region divided by the total number of 1 Mb
regions in the human genome (Table 1). We found that
under the same cutoff value for chromosomal interaction
frequency, the number of interactions at E2-treated condi-
tion was less than that in the control condition. In particu-
lar, the difference was more dramatic at a higher
interaction frequency (e.g., > = 10%) than that at the lower
one. The same trend was also observed in a repeated ana-
lysis with 2 Mb window-sizes, Additional file 1: Tables S1.
We subsequently examined the top 10 highest chromo-
somal interacting regions above 30% interaction frequencythe human genome (1Mb resolution), where the number
to 1%, 5%, 10%, 20%, 30%, 40%, 50% and 60% are



























chr3 62000001 63000000 6 0 31.4955 89 8 28.5573
chr3 63000001 64000000 16 5 32.1558 64 21 27.5008
chr3 64000001 65000000 8 8 44.5031 105 65 37.141
chr17 54000001 55000000 114 7 30.6042 308 46 25.7181
chr17 55000001 56000000 14 14 35.8864 95 62 31.9247
chr17 56000001 57000000 15 47 37.7022 110 132 32.4199
chr17 57000001 58000000 10 6 39.7161 169 36 34.2357
chr20 45000001 46000000 15 60 37.5041 244 148 31.4955
chr20 51000001 52000000 26 69 43.5787 325 182 36.4807
chr20 52000001 53000000 47 34 53.549 399 167 45.2955
The corresponding interaction frequency in E2-treated condition (T1) is also listed. ChIP-seq read count represents ERα binding intensity, and ChIP-seq binding
sites represent the number of binding sites.
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regions, where 7 of them remain above 30% interaction
frequency and the rest 3 drop to > =25% interaction fre-
quency at E2-treated condition. Although the difference of
interaction frequencies between the E2-treated and con-
trol conditions is not significant, all chromosomal regions
showed higher interaction frequency at the control condi-
tion than those at the E2-treated condition, suggesting
that the chromosomal interaction frequency may be
reduced upon E2 stimulation. To understand the ERα
binding information within these high frequency interact-
ing regions, a publicly available [13] ChIP-seq data of ERα
at the E2-treated and control condition in MCF7 cells was
used. A total number of ~1,000 and ~12,047 peaks were
called by using W-ChIPeaks [14] in control and an E2
treated dataset, respectively. These peaks were used to
examine the relationship between ER occupancy and
interaction frequency. The number of ERα binding sites
was greatly increased in the E2-treated condition in the
top 10 interaction hot regions (for instance, ~160 in E2-
treated condition verses ~30 in the control condition for
chr20:52000001:53000000; Table 2). In particular, the
results showed a significant increase in binding intensity
of ERα in E2-treated condition when compared to that
in the control condition (i.e. ~400 in E2-treated condi-
tion verse ~50 in the control condition for chr20:
52000001:53000000; Table 2). Genome-wide, the regions
with higher interaction frequencies also had higher ERα
binding occupancy: for example, at chromosome 3, 17 and
20 (Figure 1 and Additional file 1: Figures S2, 3).
In a repeat analysis using 2Mb window-sizes, similar
results were obtained (Additional file 1: Figures S4, 5, 6).
This suggests that E2 may have a higher chance to trigger
stronger ERα binding and regulate genes at the higher
interaction frequency regions. As a result, three loci close
to the top 10 interaction hot regions were selected, includ-
ing THRAP1 (17q23), INTS2 (17q23) and CADPS (3p14),genes within a higher interaction frequency region (i.e.
chromosomal interaction frequency >30% in E2 treated
condition), and C16orf65 (16p12) from a middle level
interaction frequency region (i.e. chromosomal interaction
frequency ~7% in E2 treated condition), and ZIM2
(19q13) as a negative control (i.e. chromosomal inter-
action frequency ~3% at E2 treated condition), to validate
the E2-treated chromosomal interactions by quantitative
3C-PCR (3C-qPCR). The interaction was observed in
THRAP1, INTS2, CADPS and C16orf65 loci upon 1 hr of
E2 treatment (Additional file 1: Figure S7).
Linking chromatin interaction with genome
rearrangement
Cancer cells are highly disrupted. For MCF7 cells, a pre-
vious study [13] has shown that a total of 314 (157 pairs)
break-points were induced by somatic rearrangement
using BACs combing with pyrosequencing techniques.
Interestingly, we observed a high overlap rate between
the hot 10 regions and genomic break and fusion sites.
By comparing a total of 314 break-points, 69 of 314
(22%) are within the top 10 hot regions identified in our
study (P < 1E-20) while only 1 is within the top 10 cold
regions. This may suggest interaction hot regions on
chromosome 3, 17, 20 are frequently rearranged in
MCF7 cells. However, a primary concern of identifying
chromatin interaction is that fusion sites produced by
genomic rearrangement might introduce false positive
interactions between two physically joint loci. Several
lines of evidence may ease this concern. First, one ad-
vantage of the Hi-C protocol is that the hybrid junctions
are labeled with biotin; therefore, if a junction was
caused by a rearrangement, no biotin label is added and
it cannot be pulled down by avidin. Thus, theoretically,
Hi-C protocol can eliminate these types of artificial
interactions due to the genomic rearrangements. Second,
in a recent study in K562 cells [15], no interaction
Figure 1 Chromosomal interaction hotspots. Upper panel: intra-chromosomal interaction for chromosome 20 at control condition; down
panel: intra-chromosomal interaction for chromosome 20 at E2-treated condition; right panel, red smooth line represents detected number of
ERα binding sites in the region (1 Mb resolution), and blue smooth line is the maximum read counts in the region (1 Mb resolution); left panel,
chromosomal interaction hot regions (within amplified regions) that identified by this study are colored by blue bar at X-axis and Y-axis,
respectively; positive and negative Z-scores are colored by red and green color, which indicate the observed chromosome region has higher and
lower interaction frequency than the average, respectively.
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tance of 25 identified fusion sites. Third, another recent
study demonstrated that three-dimensional organization
of genome contributes to chromosomal translocations in
mouse leukemia virus (A-MuLV) which transformed
pro-B cells by combining Hi-C and high-throughput
genome-wide translocation sequencing (“HTGTS”) ana-
lysis [16]. The same study found that intra-chromosomal
translocation frequency is correlated with Hi-C contact
probability.
Although we did not perform HTGTS in this study,
nevertheless, our simple comparison between fusion
sites and interacting regions suggests that the highest
frequency interactions may facilitate the chromosome
translocation in this breast cancer cell line. We further
speculate that chromosome translocation may further
enhance the chromatin reorganization at the junction re-
gion and promote the formation of chromatin inter-
action. Such an intensive interactive environment may
increase the chance of aberrant DNA amplification, and
thus form multiple copy number inverted repeats or
tandem repeat regions on these chromosomes. The inter-
chromosomal interactions identified between these fusion
sites may represent actual intra-chromosomal interactions
on the rearranged derivative chromosome in the cancer
cell. Taken together, our initial results suggest a link be-
tween chromosomal interactions with translocations in
the breast cancer model system.
Characterization of E2/ERα-regulated genes in both
highest and lowest frequency chromosomal interacting
regions
In the top 10 hot regions (i.e., highest frequency chromo-
somal interacting regions), there are 69 E2/ERα-regulated
genes. Functional gene ontology (GO) analysis (Table 3)
shows that the top GO biological processes are protein
amino acid dephosphorylation and intracellular receptor-Table 3 Functional annotation of genes located in the top 10
chr18 and 1 in chr22) and the top 10 hot (3 in chr3, 4 in chr1
using DAVID







(2 genes); phosphatidylcholine metabolic
process (2 genes); ethanolamine and
derivative metabolic process (2 genes);













protein amino acid dephosphorylation (4
genes); dephosphorylation (4 genes);
phosphoprotein phosphatase activity (4
genes); intracellular receptor-mediated
signaling pathway (3 genes); clathrin coat








The top 5 of each functional annotation are presented here.mediator signaling pathways. Tissue expression study of
those genes suggests that they are highly enriched in
breast (mammary gland) cancer disease, mammary gland
normal, mammary gland neoplasia and ovary neoplasia.
More importantly, those genes are often linked to human
disease such as breast cancer and adult human height. A
more detailed description of functional annotation results
are listed in Additional file 2. Correlation coefficient of
expression (~54 genes) profiles [17] between the E2-
treated and control conditions is ~0.99, which suggests
that E2 stimulation may not alter expression levels of
genes in higher frequency chromosomal interaction
regions dramatically (Additional file 1: Figure S8). Taken
together, the identified 10 hot regions (i.e. interaction fre-
quency > =30%; Table 2) contain many genes that are
linked to human disease such as breast cancer, which indi-
cates that chromosomal regions with higher interaction
frequency may play a pivotal role in genome regulation.
For comparison purposes with the top 10 hot regions,
the top 10 cold regions with the lowest interac-
tion frequency was also studied (i.e. interaction fre-
quency < =0.5% at control condition). There are 45 genes
in the top 10 cold regions (Additional file 3). The result
of functional annotation GO [18] analysis reveals that
genes located in cold regions are enriched in phosphat-
idylcholine biosynthetic process, phosphatidylcholine
metabolic process, ethanolamine and derivate metabolic
process. For tissue expression tests [18], genes of inter-
action cold regions are often linked to thalamus, testis,
brain and cardiac myocytes (Table 3). However, genes of
hot regions are linked to breast cancer disease such as
BACH1, RAD51C, CYP24A1 and NCOA3. Such func-
tional difference between genes located in the chromo-
somal interaction hot regions and cold regions is also
observed in the top 50 interaction hot (280 genes) and
cold regions (500 genes), respectively (Additional file 1
Table S2; Additional file 4 and Additional file 5). Incold (1 in chr5, 5 in chr9, 1 in chr13, 1 in chr15, 1 in















affecting diversity of adult
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sites detected in the chromosomal interaction hot
regions but none of them appeared in the interaction
cold regions. Thus, the results suggest that estrogen
may stimulate those mammary-specific genes of higher
frequency interaction with other genomic regions to
drive the breast tumorigenisis.
Next, we examined whether these breast cancer related
genes were associated with genomic break and fusions.
Interestingly, we found that two of five genes, namely
RAD51C and NOCA3, have DNA break sites within the
gene body region. In contrast to the well-known chromo-
some 9 and 22 fusion (Philadelphia chromosome) in
human chronic myelogenous leukemia or the transloca-
tion of ETS family transcription factors in prostate cancer,
no dominant causal gene fusion events in breast cancer
patients has yet been reported. The difference between
these cancers combined with the observation that breast
cancer genes are enriched within chromatin interaction
hot regions which has a high rearrangement rate suggests
a critical role of chromatin interactions in breast cancer.
This result indicates another potential pathway for breast
cancer development, in which, oncogenes might be
brought to an intensive interacting environment such as
these hot regions, thus more subject to the chromosome
translocation.
Next, the selected top 10 cold and hot regions were
compared to a previous study conducted by the ChIA-
PET in MCF7 cells [19], a different technology to identify
E2/ERα regulated chromatin interactions. Interestingly,
the identified top 10 hot regions in this study are overlap-
ping with interaction regions identified by ChIA-PET
experiments (Additional file 6). However, for the top 10Figure 2 Correlation coefficient matrices of intra-chromosomal intera
correlation coefficient matrices of chromosome 20 intra-chromosomal inte
and between control and E2-treated conditions, respectively. Here positive
green, respectively.interaction cold regions, none of them are matched to the
interaction regions provided by Fullwood et al. This com-
parison not only validated our technology and analysis but
also further supported a notion that highly frequent inter-
action regions such as the top 10 hot interaction regions
truly exist. The high interaction regions may drive breast
cancer development and progression.
Quantification of E2-mediated differential chromosomal
interactions
After revealing the correlation between chromosomal inter-
action frequency and gene regulations such as gene ex-
pression and epigenetic modifications (Additional file 1:
Figures S9 and S10) in E2-treated and control condi-
tions, respectively, we wanted to further quantitatively
measure the difference of chromosomal interactions be-
tween the E2-treated and control conditions. First, we
plotted the differential chromosomal interactions heatmap
comparing the overall interaction frequency changes be-
fore and after E2 treatment. The results suggest that the
overall chromosome interaction frequency and pattern are
changed for all chromosomes (i.e. Figure 2, chromosome
20, the intra-chromosomal interaction frequency and pat-
tern are clearly changed before and after E2 treatment).
Then, by calculating a relative ratio (see Methods section)
for each pair of interacting 1Mb window-size regions be-
tween the two conditions, a human chromosomal inter-
action change could be estimated. The distribution of the
relative ratios for all regions (Figure 3) showed that a ma-
jority (~94%) of absolute relative ratios close to 2 (i.e. a
greater than 10-fold change of interaction strength between
the two conditions). A similar pattern was also observed in
2Mb window-size (Additional file 1: Figures S11, 12). Thisctions. Left, middle and right panel represent colored heat map of
ractions (1 Mb resolution) in control condition, E2-treated condition,
and negative correlation coefficients are color scaled to red and
Figure 3 Distribution of relative ratios of chromosome interaction changes. Upper panel: Histogram of relative ratios (chromosomal
interaction changes in 1 Mb resolution, E2-treated vs control condition). Lower panel: sorted relative ratios, red smooth line is relative ratio equals
0.67 (e.g., a 2 fold change) and green smooth line is relative ratio equals 1.33 (e.g., a 5 fold change). Non-interaction elements are excluded from
analysis such as Z-score equals 0 in both control and E2-treated interaction matrices. A 10-fold interaction change is expected when the relative
ratio equals 1.63, gain and lost interactions are equivalent to the relative ratio 2 and −2, respectively.
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strengthened or weakened after E2-treatment.
An interaction change with an absolute relative ratio of 2
and the corresponding Z-scores of larger than 1 is defined
as a strong chromosomal interaction change between
the E2-treated and control conditions (Additional file 1:
Table S3). This can be further classified into four types,
the gain- or loss-, intra- or inter-chromosomal interactions.
A detailed list of the four types of interactions is shown in
Additional file 7. We observed that there are more than
three times the number of gain-intra-chromosomal interac-
tions than the number of loss-intra-chromosomal interac-
tions at E2-treated condition and, by contrast, the number
of gain-inter-chromosomal interactions are much less thanthe number of loss-inter-chromosomal interactions under
the same condition. In total, the number of gain-
chromosomal interactions is less than the number of
loss-chromosomal interactions at E2-treated condition.
A similar trend was also observed in the analysis of a
dataset with a smaller chromosomal interaction change
(i.e. with the absolute relative ratio > = 0.67 and Z-
score is not zero; Additional file 1: Table S4).
A genome-wide plot of the distribution of strong
chromosomal interaction changes along 23 human
chromosomes (Figure 4) showed that that the frequency
of gain- and loss- interactions in every region (1Mb
resolution) is symmetrically distributed along the chromo-
somes. A repeated analysis in 2Mb resolution showed
Figure 4 Dynamical changes of chromosomal interactions between control and E2-treated conditions. Number of gained (i.e. red smooth
line, positive value) and lost (i.e. blue smooth line, negative value) interactions between control and E2-treatd conditions are calculated for every
1 Mb region of human genome based on the four types of the strongest chromosomal interactions (i.e. strong differential gain or loss
chromosomal intra or inter interactions, Additional file 7).
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Additionally, a scatter plot of the rank order of the num-
ber of gain or loss chromosomal interactions verses the
number of putative ERα binding sites for 3,029 chromo-
some regions in human genome was made (Figure 5),
which showed the higher interaction frequency and the
more ERα binding sites are found. In particular, we
observed that seven of the top 10 regions with the most
gain- or loss interactions (Additional file 1: Table S5) are
overlapping with the top 10 hot regions (Table 2). To-
gether, our results demonstrated that genome-wide
chromosomal interactions are changed before and after
E2 treatment. For example, inter-chromosomal interac-
tions were gained but higher chromosomal interaction fre-
quency was reduced upon estrogen stimulation. More
importantly, chromosomal interaction frequency is posi-
tively associated with the number of ERα binding sites.
Correlation between E2-mediated differential
chromosomal interactions and epigenetic modifications
To determine correlations among chromosomal inter-
action frequency, epigenetic marks and transcriptional
regulation, eight publicly available histone marks [20]
(H3K4me1, H3K4me2, HK4me3, H3K9me2, H3K9me3,
H3K27me3, H3K9ac, H3K14ac), DNA methylation, Pol-
II level and regulatory activity (FAIRE) were used to cal-
culate the log transformation of read counts for genes
within every 1Mb window-size region. Here ~16% of
1 Mb chromosome regions (480) were excluded from
the analysis because there is no gene in these regions. In
order to determine the role of each specific regulatoryregion for any given gene, we further divided each gene
into the three regulatory regions in reference to a 5’
transcription start site (5TSS), 5 Kb upstream, 5 Kb
downstream and gene body. Then, the mean of log
transformed read counts for each part at the 1Mb
chromosome region were computed and displayed in a
heat map (Additional file 8), with the order of chromo-
some regions sorted by the interaction frequency at the
control condition. The results showed that there is a
clear separation between the interaction hot regions
(regions with the highest chromosomal interaction fre-
quency; lowest panel of Additional file 8; Additional file 1:
Figure S9) and the interaction cold regions (regions with
the lowest chromosomal interaction frequency; top panel
of Additional file 8; Additional file 1: Figure S9).
In order to understand the epigenetic influence on
four types of interactions and gene regulation, a t-test
was used to evaluate the significance of changes on
six histone marks (H3K4me1, H3K4me3, H3K9me3,
H3K27me3, H3K9ac, H3K14ac), Pol-II level and regula-
tory activity (FAIRE), between the E2-treated and con-
trol conditions on genes (~21,136 genes) located in the
four types of interacting regions. Two histone marks
(H3K4me2 and H3K9me2) and DNA methylation were
not included in the analysis due to lack of E2-treated
condition. The result (Figure 6) showed that H3K4me3,
H3K27me3, H3K9ac and H3K14ac are increased in the
E2-treated condition when compared to the control con-
dition for four types of chromosomal changes, while
H3K9me3 and Pol-II are decreased upon E2 treatment.
Furthermore, the H3K4me1 level remains unchanged
Figure 5 Association of chromosomal interaction frequency and ER-alpha binding motifs. ER-alpha binding motifs are identified by
applying peak calling program wBELT on public available ER-alpha Chip-Seq experiments. Then the number of ER-alpha binding motifs in every
1 Mb region of human genome is plotted against to the rank order of local chromosomal interaction frequencies in Hi-C experiments. Figures
from the left to the right represent such plot in Hi-C control, E2-treated, E2-treated gained interaction only and E2-treated lost interaction only
conditions, respectively.
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ERα binding site and the chromosomal interaction fre-
quencies show that the former one is highly enriched at
the E2-treated condition but the latter one is reduced at
the same condition. A similar result was also obtained
by performing a Mann–Whitney U test on the same
data as well as performing a t-test on data with 2Mb
window-sizes. It suggests that the results are robust and
not subject to change based on different window-size
[21] (see Additional file 1: Figure S13,14).
Thus, our results revealed several interesting relation-
ships among chromosomal interaction, histone modifica-
tions and gene regulations (Figure 6): 1) H3K4me3, two
histone acetylation marks (H3K9ac and H3K14ac), as
well as H3K27me3 levels are significantly enriched upon
estrogen stimulation. From literature, we knew that the
former three histone marks are always enriched in active
genes [22] while the latter one is enriched in repressed
genes [23]. In particular, both active and repressive
marks can coexist led to the “bivalent domain” model
and the regions maintain low transcription state [24,25];
2) H3K4me1 level is not affected by the change of
chromosomal interactions (i.e. a strong positive correl-
ation in Additional file 1: Figure S10), H3K4me1 is
known for its involvement in enhancer activity especially
in the active distal regulatory region; 3) both repressor
mark H3K9me3 and Pol-II levels are decreased in the
E2-treated condition for all four types of chromosomal
interactions. These results suggest that E2-mediated
switching change of chromosomal interactions may be
epigenetic regulated and influence on both positive and
negative gene regulation, as there is increasing H3K4me3
and H3K9ac levels but decreasing H3K9me3 levels after
E2-treated in MCF7 cells.Characterization of E2/ERα-regulated genes in high
frequent and strong differential chromosomal
interactions
Next, we wanted to examine the genes in the top 10
regions with the most gain- or loss- interactions upon
E2 treatment (Additional file 1: Table S5). There are 79
genes located in these regions and we thus performed
GO annotation on those 79 genes (a detailed description
in Additional file 9). The results are similar to the top 10
hot regions: GO annotation shows genes are mainly
involved in intracellular signaling cascade and in the
intracellular receptor-mediated signaling pathway; tissue
expression analysis reveals that breast (mammary gland)
cancer disease 3rd and mammary gland carcinoma 3rd
are significantly enriched, as well as breast cancer is
among the most significant disease link to the regions.
In particular, a protein interactions study reveals that
those genes are potentially co-regulated or co-targeted
by a wide range of transcription factors (i.e. more than
eighty TFs; Additional file 9) such as FOXO1, FOXO4,
FOXJ2, LHX3, HFH3, HFH1, OCT and HNF1. This is also
true for genes that are located in the top 10 or 50 hot
regions (Table 2; Additional file 2 and Additional file 4),
and is consistent with previous observation in Figure 5,
the higher the interaction frequency the higher the ERα
binding occupancy. Surprisingly, the time-course micro-
array expression profiles of those 79 genes do not show
any major changes across the 12 time points (0 hour to
32 hours; Additional file 1: Figure S15), except for a few
genes after 20 hours of E2 treatment.
To further test whether large scale chromosomal re-
organization affects gene expression, we compared the
number of differential expressed genes in these differential
interaction regions to the overall number of differential
Figure 6 A heat map of change of histone modifications
between E2-treated and control conditions for four types of
chromosomal interactions. Here T-values are obtained by perform
t-test for genes that were chosen by the identified four types of
chromosomal interaction changes (e.g., gain strong inter-chromosomal
interaction, loss strong inter-chromosomal interaction, gain strong
intra-chromosomal interaction and loss strong intra-chromosomal
interaction, detailed information please refer to Additional file 7). The
T-test was used to evaluate significance of dynamical change of
various marks between E2-treated and control conditions (1 Mb
resolution), positive and negative T-values are colored by yellow and
blue, respectively. In the figure, 0, +1 and −1 represent E2 treated
condition vs. control condition at gene body, 5 kb upstream and 5 kb
downstream, respectively.
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square analysis showed that regions gained or lost intra-
chromosomal interactions, however inter-chromosomal
interactions were no more subject to expression change
than overall genes. The p values of the Chi square tests
were as follows: loss intra-chromosomal interaction vs.
overall – p < 0.0001; gain intra-chromosomal interaction vs.
overall – p < 0.0001; loss inter-chromosomal interactionvs. overall – p = 0.113; and gain inter-chromosomal
interaction vs. overall – p = 0.619. This result suggests
distinct roles of inter-chromosomal interactions and intra-
chromosomal interactions in gene regulation. A small por-
tion of the gene expression was affected by chromosomal
interaction changes indicating that chromatin organization
is one of the many factors involved in gene regulation.
Discussion
Although recent advances in high throughput technolo-
gies (i.e. ChIP-seq and DNase-seq) have been effectively
applied to map transcription factors binding sites and
histone modifications on the linear DNA sequence, in
the one-dimensional (1D) regulatory view, these techni-
ques are not sufficient to provide information of how
gene expression is transcriptionally modulated in the
three-dimensional (3D) chromatin architecture. Two re-
cent pioneering studies [3,16] developed a new Hi-C
protocol and revealed the extensive genomic interac-
tions. However, they are limited on a single time point
Hi-C experiment which can only depict a static chroma-
tin structure. By applying this new emerging technology
on a breast cancer model system, before and after estro-
gen treatment on MCF7 (an ERα positive breast cancer
cell line), we comprehensively analyzed the Hi-C data
performed in our laboratory and revealed a dynamic
chromatin re-organization upon E2 stimulation resulting
in altered gene regulation and their associations with
epigenetic modification states. Our work provides further
insight into the effect of chromatin interaction on E2/ERα
regulated downstream genes in breast cancer cells.
Several studies support a notion that long-range regu-
lation of many critical genes may be involved in both
normal development and disease [5,10,11,26-28]. A re-
cent study showed that genes with similar functions
form a multi-gene complex through chromatin interac-
tions and cooperatively expressed at a high level [29].
Interestingly, by GO analysis, we found that breast can-
cer associated genes are enriched in highly interactive
regions (i.e. chromosomes 17 and 20) in MCF7 cells.
Our results indicate that the disease related genes might
be co-upregulated in breast cancer cells due to the high
order structure changes of the chromatin (Table 2).
Genes in low chromosomal interaction frequency
regions may not contribute to the development of cancer,
but genes in high interaction frequency regions (> = 30%)
may be essential to human disease such as breast cancer.
Our study also suggests that the dynamic chromo-
somal interaction switches are frequently occurring in
the chromosomal interaction hot regions (i.e. chromo-
somes 17 and 20; Table 2) after E2 treatment. Those
regions contain genes not only highly associated with
breast cancer but also actively participating in signaling
cascade and signaling pathways. Though gene expression
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the interaction hot regions, they interact with a wide
range of TFs such as FOXO1. Thus, chromosome inter-
action hot regions are potentially very important to
functional genome regulation because they bear active
chromosome interaction upon E2 stimulation, and the
regions may function as a harbor to recur many TFs for
initiating more activities in the downstream gene regula-
tions such as histone modifications.
Conclusions
Our study is among one of the first attempts to profile
genome-wide dynamic chromatin re-organization in re-
sponse to environmental changes. We observed both ex-
tensive looping and de-looping events in MCF7 cells after
E2 treatment, and discovered that dynamic changes of
both inter- and intra-chromosomal interactions do exist
with predominate inter-chromosomal changes. Further,
we found both active (H3K4me3, H3K9ac) and repressive
(H3K27me3) histone modification changes associated with
interaction gain or loss. This result indicated a dual-role of
chromatin structure change on transcriptional regulation,
one part of the chromatin territories forms a co-activate
complex while the other part of the chromatin forms a co-
repressive complex. We linked the dynamic organization
to major transcription factors associated with disease de-
velopment, in this case estrogen receptor α, and transcrip-
tional regulation. In addition, a strong negative correlation
between interaction and nucleosome density (FAIRE level)
provided evidence of the cooperative regulation of genes.
These results strongly suggest that environmental stimula-
tion can trigger the re-organization of the chromatin,
which can further impact regulation of critical genes. The
elucidation of the association between chromatin inter-
action and critical genes may shed light on the underlying
mechanisms of disease development and progression.
Methods
Hi-C Method
MCF-7 cells were grown in a medium with 5% charcoal/
dextran-stripped fetal bovine serum (HyClone) for 24
hours and then stimulated with 17β-estradiol (E2, 70 nM)
or DMSO (Control) for 1 hour. Treated cells were then
subjected to Hi-C as previously described [3]. Briefly, cells
were cross-linked with 1% formaldehyde. DNA was
digested with HindIII to create a 5’ overhang. The 5’ over-
hang was filled within including a cytosine-biotinylated
residue. The resulting blunt-end fragments were ligated by
T4 ligase under diluted conditions that favor ligation
events between the cross-linked DNA fragments. Ligated
DNA was then de-cross-linked (overnight at 65°C) and
purified by phenol extraction procedures. Ligated DNA
(5 μg) was randomly sheared by a nebulizer supplied with
the Illumina paired-end sample preparation kit, thenapplied to paired-end sequencing as per the manufacturer’s
instructions by using the Illumina Genome Analyzer IIA.
For each time point, four technical replicates of Hi-C
experiments were performed. Correlation analysis and
scatter plot of these replicates are shown in Additional
file 1: Figures S16 and Table S6. In this study, all reads of
replicates were combined for downstream data analysis, a
total of ~125 and ~111 million raw paired 51 bp sequence
reads were obtained for control and E2 treatment respect-
ively. After aligning to the Human Genome Assembly
(NCBI build 36.1/hg18) using the ELAND algorithm and
removing redundant reads in order to reduce DNA ampli-
fication and system biases, a total of ~92 and ~80 million
reads were uniquely mapped to the human genome. In
order to minimize the effect by genomic regions ampli-
fied in MCF7, all duplicated pair-end interactions were
removed.
Chromosome interaction frequency
After pre-processing [12], normalization and transform-
ation of Hi-C interaction data to Z-scores, distribution
of chromosomal interaction frequencies of both control
(T0) and E2 treated experiments (T1) were studied in 1
Mb resolution. Specifically, for every 1Mb window-size
of chromosome regions, the number of interactions
(Z-scores not equal to zero) between the region and the
rest of the chromosome regions were counted. The
chromosomal interaction frequency of the region was
then calculated as the counted number of interactions in
the region divided by the total number of chromosome
regions (e.g. with 1Mb resolution, there are 3,029
chromosome regions in the human genome). Z-score of
intra- or inter-chromosomal interaction matrices (raw
interaction counts in 1Mb resolution divided by the
average expected level of interactions [12]) are illustrated
in both the genome-wide heat map and chromosome spe-
cific intra-chromosomal interaction heat map. Relative
ratios [30], i.e. the difference of exponential Z-score be-
tween the two conditions divided by the average of
Z-scores of chromosome interaction changes between
control and E2 treated conditions are used to investigate
the dynamic feature of chromosomal interactions between
control and E2 treated experiments, where zero elements
(no interaction) remain as zero.
Processing ChIP-seq of histone modifications, ERα and
Pol-II, MBD-seq and FAIRE-seq data
Histone modification datasets (e.g., H3K14ac, H3K27me3,
H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me2 and
H3K9me3), DNA methylation, DNA accessible regions
(FAIRE), Pol-II and ERα ChIP-seq data under both E2
treated and control conditions were publically collected
[13,20,31]. Preprocessing of the above-mentioned ChIP-
seq datasets were accomplished by BALM [32] such as
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(t-test and Mann–Whitney U test) between E2 treated
and control conditions was adopted from a previous study
[33]. Gene expression profiles for E2 stimulated MCF-7
cells were taken from the study [17] and preprocessed by
MArray [34]. The DAVID tool was used to perform func-
tional annotation of gene analysis [18].Validations of ERα regulated interaction by quantitative
3C-PCR
Chromosome conformation capture assay combined with
quantitative PCR analysis (3C-qPCR) was performed as
previously described [19]. Briefly, MCF-7 cells were treated
with E2 (70 nM) for 1 hr and then fixed with 1% formalde-
hyde. Chromatin was digested using BbvCI (for ESR1) and
BamHI (for target loci), and then ligated by T4 DNA.
Ligated DNA was then de cross-linked (overnight at 65°C)
and purified by classical phenol extraction procedures.
Real-time PCR was performed on a 7500 Real-Time PCR
System apparatus (Applied Biosystems) using the TaqMan
technology (QuantiTect Probe PCR Master Mix, Qiagen).
We used a 59FAM-39BHQ1 oligonucleotidic probe (IDT).
Five loci, including THRAP1 (17q23), INTs2 (17q23),
C16orf65 (16p12), CADPS (3p14) and ZIM2 (19q13), were
chosen to examine the interactions. We utilized ERα bind-
ing sites (ERαBS) located at the 20q13 region as the bait to
interrogate the interactions between ERαBS and promoter
regions of three loci. To rule out the possibility of false-
negative looping occurrence caused by unsuccessful 3C
assay, we pooled three human bacterial artificial clones
(BAC), mapping the interested regions as the positive con-
trol to the 3C assay. BACs were also used to examine the
primer efficiency. Ct values obtained for each chimerical
ligation fragment were processed using parameters of a
standard curve (slope and intercept) from BAC to obtain
quantification values that were normalized to a GAPDH
loading control. Results are presented as the mean of tripli-
cates with standard derivation.Additional files
Additional file 1: Additional Figures and Tables. Contains all
additional tables and figures.
Additional file 2: DAVID results for genes in chromosomal
interaction hot regions. Contains DAVID results of 69 genes located in
the top 10 chromosomal interaction hot regions.
Additional file 3: DAVID results for genes in chromosomal
interaction cold regions. Contains DAVID results of 45 genes located in
the top 10 chromosomal interaction cold regions.
Additional file 4: DAVID results for genes in chromosomal
interaction hot regions. Contains DAVID results of 280 genes located in
the top 50 chromosomal interaction hot regions.
Additional file 5: DAVID results for genes in chromosomal
interaction cold regions. Contains DAVID results of 500 genes located
in the top 50 chromosomal interaction cold regions.Additional file 6: Comparing 69 genes at interaction hot regions
with Fullwood’s results. Contains a comparison between 69 genes at
the top 10 chromosomal interaction hot regions and Fullwood’s results.
Additional file 7: Strong chromosomal interaction changes.
Contains chromosome regions with strong interaction changes under the
E2 treated condition (e.g. Zscore > 1 and Relative ratios = 2).
Additional file 8: Additional Figure. Contains an additional figure that
shows the correlation between histone modification and chromosomal
interaction frequency for all interaction regions in 1Mbp resolution. The
order of chromosome regions is sorted by their interaction frequency at
the control condition.
Additional file 9: Genes of top 10 regions with the most gained
and lost interactions according to four types of strong
chromosomal interaction changes. Contains results of functional
annotation of genes in the top 10 most frequent dynamical
chromosomal interaction regions. The regions are estimated from four
types of strong chromosomal interaction changes.
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